Your browser doesn't support javascript.
loading
Compound heterozygous missense mutations in a Chinese mucopolysaccharidosis type VI patient: a case report.
He, Ming-Fang; Yang, Ji; Dong, Meng-Jie; Wang, Yin-Ting; Liu, Hai.
Afiliação
  • He MF; Department of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
  • Yang J; The Eye Disease Clinical Medical Research Center of Yunnan Province, Kunming, China.
  • Dong MJ; The Eye Disease Clinical Medical Center of Yunnan Province, Kunming, 650000, China.
  • Wang YT; Department of Ophthalmology, Affiliated Hospital of Yunnan University, Second People's Hospital of Yunnan Province, Kunming, China.
  • Liu H; The Eye Disease Clinical Medical Research Center of Yunnan Province, Kunming, China.
BMC Ophthalmol ; 21(1): 214, 2021 May 13.
Article em En | MEDLINE | ID: mdl-33985463
BACKGROUND: Mucopolysaccharidosis type VI (MPS VI) is a rare autosomal recessive inherited disease caused by mutations in the arylsulfatase B (ARSB) gene. MPS VI is a multisystemic disease resulting from a deficiency in arylsulfatase B causing an accumulation of glycosaminoglycans in the tissues and organs of the body. In this report, we present the case of a 16-year-old Chinese male who presented with vision loss caused by corneal opacity. MPS VI was confirmed by genetic diagnosis. CASE PRESENTATION: A 16-year-old Chinese male presented with a one-year history of binocular vision loss. The best-corrected visual acuity was 0.25 in the right eye and 0.5 in the left eye. Although slit-lamp examination revealed corneal opacification in both eyes, the ocular examinations of his parents were normal. At the same time, the patient presented with kyphotic deformity, short stature, joint and skeletal malformation, thick lips, long fingers, and coarse facial features. Genetic assessments revealed that ARSB was the causative gene. Compound heterozygous missense mutations were found in the ARSB gene, namely c.1325G > A (p. Thr442Met) (M1) and c.1197G > C (p. Phe399Leu) (M2). Genetic diagnosis confirmed that the patient had MPS VI. CONCLUSIONS: This paper reports a case of MPS VI confirmed by genetic diagnosis. MPS VI is a multisystem metabolic disease, with corneal opacity as a concomitant ocular symptom. As it is difficult for ophthalmologists to definitively diagnose MPS VI, genetic testing is useful for disease confirmation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mucopolissacaridose VI / N-Acetilgalactosamina-4-Sulfatase Tipo de estudo: Diagnostic_studies Limite: Adolescent / Humans / Male País/Região como assunto: Asia Idioma: En Revista: BMC Ophthalmol Assunto da revista: OFTALMOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mucopolissacaridose VI / N-Acetilgalactosamina-4-Sulfatase Tipo de estudo: Diagnostic_studies Limite: Adolescent / Humans / Male País/Região como assunto: Asia Idioma: En Revista: BMC Ophthalmol Assunto da revista: OFTALMOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China